Skip to Content

Delaware Ivy Value A IYVAX

Medalist Rating as of | See Macquarie Investment Hub
  • NAV / 1-Day Return 17.33  /  +0.17 %
  • Total Assets 444.2 Mil
  • Adj. Expense Ratio
    1.080%
  • Expense Ratio 1.080%
  • Distribution Fee Level Above Average
  • Share Class Type Front Load
  • Category Large Value
  • Investment Style Large Value
  • Min. Initial Investment 1,000
  • Status Open
  • TTM Yield 1.33%
  • Turnover 103%

USD | NAV as of May 17, 2024 | 1-Day Return as of May 17, 2024, 11:13 PM GMT+0

Morningstar’s Analysis IYVAX

Will IYVAX outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

Weakness in Delaware Ivy Value A's People and Process Pillar ratings limits this strategy to a Morningstar Medalist Rating of Negative.

null Morningstar Manager Research

Morningstar Manager Research

Summary

Fees are a weakness here. The strategy's lofty fees are a high hurdle to clear, as it is priced within the second-highest quintile among peers.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings IYVAX

  • Current Portfolio Date
  • Equity Holdings
  • Bond Holdings
  • Other Holdings
  • % Assets in Top 10 Holdings 31.1
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

The Walt Disney Co

3.16 15.6 Mil
Communication Services

U.S. Bancorp

3.15 15.5 Mil
Financial Services

The Travelers Companies Inc

3.13 15.4 Mil
Financial Services

Exxon Mobil Corp

3.12 15.4 Mil
Energy

Motorola Solutions Inc

3.12 15.4 Mil
Technology

CVS Health Corp

3.10 15.3 Mil
Healthcare

Equity Residential

3.10 15.3 Mil
Real Estate

Northrop Grumman Corp

3.10 15.3 Mil
Industrials

DuPont de Nemours Inc

3.09 15.3 Mil
Basic Materials

TJX Companies Inc

3.09 15.2 Mil
Consumer Cyclical